Predictive Toxicology -- Strategies to Reduce Late Stage Drug Failures and Address Bottlenecks of In-vitro and In-vivo Toximetabolism Using High-Throughput Methods | |
United States - PA - Philadelphia |
|
Hosted by: | Barnett International |
Venue: | Park Hyatt Hotel |
Dates: | Sep 08, 2004 through Sep 09, 2004 |
Description |
|
$70 million of the total R&D costs per drug are spent on ADME/Tox failures! Due to the high cost of late-stage failure and the impact of adverse drug reactions, it is critical to eliminate toxic compounds as early as possible in the drug development process. This comprehensive event featuring industry, academic and agency case studies offers strategies to reduce late stage drug failures and address bottlenecks of in-vitro and in-vivo toximetabolism using high-throughput methods. |
|
Additional Information | |
Event URL: | http://www.barnettinternational.com/RSC_PDFUploads//BI4007WEB.pdf |
ISCB Member Discount: | 15 percent |
Restrictions: | May NOT be combined with any other discount or transferred to any other program. |
Contact Person: | Micah Lieberman ([javascript protected email address]) |
While ISCB provides for conference and event listings that may be of interest to members and bioinformaticians at large, ISCB is not responsible for the content provided by outside sources. Such listings are not meant as an endorsement by ISCB.